SCHEMBL7236646

SCHEMBL7236646

CCOC(=O)c1cc(CC)nn1Cc1cccc(C#N)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
POLB P06746 2/20 0.53
TDP1 Q9NUW8 5/20 0.50
RXFP1 Q9HBX9 1/20 0.49
MAPT P10636 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
ELANE P08246 1/20 0.43
TSHR P16473 1/20 0.42
GRM5 P41594 1/20 0.42
ALDH1A1 P00352 1/20 0.41
ROCK2 O75116 1/20 0.41
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
MAPK1 P28482 1/20 0.41
CFTR P13569 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231587 0.90 SMN1; SMN2 (0.54) SMN1; SMN2POLBTDP1RXFP1MAPT
SCHEMBL23070342 0.81 POLB (0.51) SMN1; SMN2POLBTDP1RXFP1KMT2A
SCHEMBL22737056 0.78 POLB (0.51) SMN1; SMN2POLBTDP1RXFP1MAPT
SCHEMBL7234307 0.77 MAPT (0.56) SMN1; SMN2POLBTDP1MAPTRAB9A
SCHEMBL20600028 0.76 MAPT (0.69) SMN1; SMN2POLBTDP1MAPTL3MBTL1
SCHEMBL7234546 0.75 CCR2 (0.51) POLBL3MBTL1KMT2AALDH1A1
SCHEMBL24828267 0.75 MAPT (0.67) SMN1; SMN2POLBTDP1MAPTL3MBTL1
SCHEMBL16347393 0.75 CYP19A1 (0.55) SMN1; SMN2POLBTDP1MAPTL3MBTL1
SCHEMBL6433289 0.75 NOD2 (0.67) SMN1; SMN2POLBTDP1RXFP1MAPT
SCHEMBL6432920 0.74 F10 (0.67) SMN1; SMN2POLBTDP1RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548512-B1 Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-15 US disclosed